Centene (NYSE:CNC) PT Raised to $82.00 at Deutsche Bank Aktiengesellschaft

Centene (NYSE:CNC) had its price target lifted by investment analysts at Deutsche Bank Aktiengesellschaft from $81.00 to $82.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 13.49% from the company’s previous close.

CNC has been the subject of several other research reports. Wells Fargo & Company raised their price target on shares of Centene from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. Stephens restated an “equal weight” rating and issued a $85.00 target price (down from $92.00) on shares of Centene in a research note on Thursday, March 21st. StockNews.com raised Centene from a “buy” rating to a “strong-buy” rating in a research note on Monday. Cantor Fitzgerald reiterated an “overweight” rating and set a $90.00 price target on shares of Centene in a report on Thursday, April 4th. Finally, Oppenheimer reissued an “outperform” rating and set a $110.00 price objective on shares of Centene in a report on Monday. Six research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $85.00.

Centene Trading Down 1.1 %

CNC opened at $72.25 on Tuesday. The company’s 50 day moving average is $75.96 and its 200-day moving average is $74.84. The company has a market cap of $38.56 billion, a P/E ratio of 14.36, a PEG ratio of 0.95 and a beta of 0.38. Centene has a 1-year low of $60.83 and a 1-year high of $81.42. The company has a current ratio of 1.17, a quick ratio of 1.11 and a debt-to-equity ratio of 0.66.

Centene (NYSE:CNC) last issued its earnings results on Friday, April 26th. The company reported $2.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.17. Centene had a return on equity of 14.19% and a net margin of 1.76%. The business had revenue of $40.41 billion during the quarter, compared to analysts’ expectations of $36.43 billion. During the same quarter in the prior year, the firm earned $2.11 EPS. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Equities research analysts predict that Centene will post 6.82 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Centene news, Director Lori Jean Robinson sold 10,000 shares of Centene stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the completion of the transaction, the director now owns 11,455 shares of the company’s stock, valued at approximately $886,731.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Centene news, President Kenneth J. Fasola sold 12,000 shares of the stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total value of $900,840.00. Following the sale, the president now directly owns 235,365 shares in the company, valued at approximately $17,668,850.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Lori Jean Robinson sold 10,000 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total transaction of $774,100.00. Following the transaction, the director now owns 11,455 shares of the company’s stock, valued at $886,731.55. The disclosure for this sale can be found here. 0.29% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Centene

Large investors have recently added to or reduced their stakes in the business. Hussman Strategic Advisors Inc. purchased a new stake in shares of Centene in the 1st quarter valued at about $1,648,000. PDS Planning Inc increased its position in shares of Centene by 5.5% in the first quarter. PDS Planning Inc now owns 3,689 shares of the company’s stock worth $290,000 after purchasing an additional 193 shares during the last quarter. Fortem Financial Group LLC lifted its position in Centene by 19.7% during the first quarter. Fortem Financial Group LLC now owns 6,335 shares of the company’s stock valued at $497,000 after purchasing an additional 1,042 shares during the last quarter. Resonant Capital Advisors LLC increased its holdings in shares of Centene by 17.8% in the 1st quarter. Resonant Capital Advisors LLC now owns 5,071 shares of the company’s stock worth $398,000 after buying an additional 766 shares during the last quarter. Finally, Blackhawk Capital Partners LLC. raised its position in shares of Centene by 9.3% during the 1st quarter. Blackhawk Capital Partners LLC. now owns 4,954 shares of the company’s stock valued at $389,000 after buying an additional 420 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.